Partial breast radiation therapy - external beam

Definition

Partial breast radiation therapy uses high-powered x-rays to kill breast cancer cells. This type of treatment does not target the entire breast, rather just the area around where the original cancer was located, sparing some normal tissue. It is also called accelerated partial breast radiation (APBI).

A standard course of whole breast directed external beam breast treatment takes 3 to 6 weeks. APBI can be accomplished in as little as 1 to 2 weeks. APBI targets a high dose of radiation only on or near the area where the breast tumor was removed. It avoids exposing the surrounding tissue to radiation.

There are three common approaches for APBI:

Alternative Names

Carcinoma of the breast - partial radiation therapy; Partial external beam radiation - breast; Intensity-modulated radiation therapy�- breast cancer; IMRT�- breast cancer WBRT; Adjuvant partial breast - IMRT; APBI - IMRT; Accelerated partial breast irradiation - IMRT; Conformal external beam radiation - breast

Description

Radiation therapy is usually delivered on an outpatient basis, except for intraoperative radiation therapy.

Two common techniques are used for partial breast external beam radiation treatment:

Before you have any radiation treatment, you will meet with the radiation oncologist. This person is a doctor who specializes in radiation therapy.

The treatment is usually given 5 days a week for anywhere from 2 to 6 weeks. It may sometimes be given twice a day (usually with 4 to 6 hours between sessions).

You are not radioactive after these radiation treatments. It is safe to be around others, including babies and children.

Why the Procedure Is Performed

Experts learned that certain cancers are most likely to return the location of the original cancer. Therefore, in some cases, the whole breast may not need to receive radiation. Partial breast irradiation only treats some but not all of the breast, focusing on the area where the cancer is most likely to return, usually around the surgical cavity.

This accelerated partial breast radiation speeds up the process.

APBI is used to prevent breast cancer from coming back. When radiation therapy is given after breast-conserving surgery, it is called adjuvant (additional) radiation therapy.

APBI may be given after lumpectomy or partial mastectomy (called breast-conserving surgery) for:

Before the Procedure

Tell your health care provider what medicines you are taking.

Wear loose fitting clothes to the treatments.

After the Procedure

Radiation therapy can also damage or kill healthy cells. The death of healthy cells can lead to side effects. These side effects depend on the dose of radiation and how often you have the therapy. Radiation can have short-term (acute) or long-term (later) side effects.

Short-term side effects can begin within days or weeks after treatment begins. Most side effects of this type go away within 4 to 6 weeks after treatment ends. Most common short-term effects include:

Long-term side effects may begin months or years after treatment and may include:

Your providers will explain care at home during and after radiation treatment.

Outlook (Prognosis)

Partial breast radiation following breast conservation therapy reduces the risk of cancer coming back, and possibly even death from breast cancer.

References

National Cancer Institute website. Breast cancer treatment (PDQ) - health professional version. www.cancer.gov/types/breast/hp/breast-treatment-pdq. Updated�February 9, 2023. Accessed February 28, 2023.

National Cancer Institute website. Radiation therapy and you: support for people who have cancer. www.cancer.gov/publications/patient-education/radiation-and-you-2021-508.pdf. Updated April, 2021. Accessed November 18, 2022.

Shah C, Harris EE, Holmes D, Vicini FA. Partial breast irradiation: accelerated and intraoperative. In: Bland KI, Copeland EM, Klimberg VS, Gradishar WJ, eds. The Breast: Comprehensive Management of Benign and Malignant Diseases. 5th ed. Philadelphia, PA: Elsevier; 2018:chap 51.


Review Date: 7/23/2022
Reviewed By: David Herold, MD, Radiation Oncologist in Jupiter, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. Editorial update 02/28/2023.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language. � 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
� 1997- adam.comAll rights reserved.